BPCE
BNTX icon

Bank Pictet & Cie (Europe)’s BioNTech BNTX Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,505
Closed -$226K – 175
2022
Q4 		$226K Buy
+1,505
New +$232K 0.01% 157

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s BNTX Position: Q1 2023 in Review

Bank Pictet & Cie (Europe) sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 1,505 shares — an estimated $226K sold.

Bank Pictet & Cie (Europe) first reported a position in BNTX in Q4 2022 and held it in 1 quarter. The position peaked at $226K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Bank Pictet & Cie (Europe) reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 1,505 BioNTech shares in Q1 2023, an estimated $226K.
  • Bank Pictet & Cie (Europe) first reported a position in BioNTech in Q4 2022 and held it in 1 quarter.
  • Bank Pictet & Cie (Europe)'s BioNTech position peaked at $226K in Q4 2022.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2023, filed 1 May 2023.